Tag: pharma grade calcium sulphate market growth

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Pharma Grade Calcium Sulphate Market Growth Potential: How Will Market Size Shift Through 2030?

Recent years have seen robust growth in the pharma grade calcium sulphate market size. The market is projected to expand from $0.96 billion in 2025 to $1.04 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. Historically, this growth has been driven by factors such as an increase in pharmaceutical manufacturing, a greater demand for solid dosage forms, the expansion of generic drug production, the increasing adoption of calcium-based excipients, and a stronger regulatory focus on excipient quality.

The pharma grade calcium sulphate market is anticipated to show significant expansion in the upcoming years. It is projected to attain a size of $1.44 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.4%. This growth during the forecast period can be attributed to factors such as the increase in global drug production, the growing application of high-performance excipients, an escalating demand for consistent formulation quality, the enlargement of nutraceutical manufacturing, and advancements in excipient processing. Prominent trends expected in this period include an increasing requirement for high-purity pharmaceutical excipients, their expanding use in tablet and capsule formulations, rising adoption in calcium supplement manufacturing, the broadening of quality-controlled excipient production, and an amplified focus on materials that comply with regulatory standards.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=35208988&type=smp&name=Pharma%20Grade%20Calcium%20Sulphate%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Pharma Grade Calcium Sulphate Market Growth Momentum: What Factors Are Shaping Demand?

The increasing need for pharmaceutical products is projected to boost expansion in the pharma grade calcium sulphate market. Pharmaceuticals are defined as medicines and drugs created, produced, and utilized for the diagnosis, treatment, or prevention of illnesses in both humans and animals. This escalating demand for pharmaceuticals largely stems from the increasing incidence of chronic ailments, compelling a greater number of people to rely on extended medication regimens for managing conditions like diabetes, cardiovascular disorders, and cancer. As a high-purity excipient, pharma grade calcium sulphate improves pharmaceutical formulations by guaranteeing uniform tablet hardness, overall stability, and the regulated release of active components. For example, data from Eurostat, the European Union’s official statistical agency based in Luxembourg, revealed in April 2024 that the EU’s imports of medicinal and pharmaceutical goods rose by 6.1% in 2023, reaching a total of $137.4 billion (€119 billion) when compared to the prior year. Over the identical timeframe, EU exports amounted to $319.2 billion (€277 billion), leading to a significant trade surplus of $182.0 billion (€158 billion). Consequently, the increasing need for pharmaceuticals is a key factor propelling the expansion of the pharma grade calcium sulphate market.

Pharma Grade Calcium Sulphate Market Segmentation: How Does The Market Break Down By Category?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

Pharma Grade Calcium Sulphate Market Trends Redefining Industry Growth

Leading companies in the pharma grade calcium sulphate market are concentrating on creating novel products, leveraging synthetic medical-grade bassanite to improve the purity and consistency of their calcium sulphate offerings. This synthetic medical-grade bassanite, identified as CaSO₄·0.5H₂O and characterized by its high purity and partial dehydration, facilitates the production of pharma-grade calcium sulphate by supplying a uniform, uncontaminated material that adheres to rigorous regulatory requirements for medical and pharmaceutical purposes. An example of this trend is the launch in February 2025 by Sree Chitra Tirunal Institute for Medical Sciences & Technology, an Indian medical institution, of Caspro & Bonyx. These are pioneering drug-eluting bone graft products, also developed with synthetic medical-grade bassanite to guarantee elevated purity, biocompatibility, and regulated drug delivery for sophisticated orthopedic uses. Caspro itself is a self-hardening, malleable bone cement composed of calcium sulfate hemihydrate fortified with phosphate ions, making it suitable for filling bone defects and releasing drugs at the implantation site for over 21 days. Bonyx, on the other hand, comprises osteoconductive bioceramic beads that can be vacuum-filled with antibiotics or other liquid medications, allowing for sustained drug release for more than 30 days. Such products signify a substantial advancement in localized treatment for bone infections and regeneration, illustrating the potential of pharma-grade calcium sulphate in advanced biomedical solutions that comply with strict international benchmarks.

Pharma Grade Calcium Sulphate Market Competitive Overview And Top Companies

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères

View The Full Pharma Grade Calcium Sulphate Market Report:

https://thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Pharma Grade Calcium Sulphate Market Geographic Distribution And Regional Opportunities

North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Pharma Grade Calcium Sulphate Market Expansion From $1.04 Billion In 2026 To $1.44 Billion In 2030

The market for pharma-grade calcium sulphate has seen notable expansion over the past few years. Its valuation is projected to rise from $0.96 billion in 2025 to $1.04 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. This historic growth is driven by factors such as the expansion of pharmaceutical manufacturing, a higher demand for solid dosage formats, increased production of generic medications, greater utilization of calcium-based excipients, and a regulatory focus on excipient quality standards.

During the upcoming years, the market for pharmaceutical-grade calcium sulphate is anticipated to experience considerable expansion. By 2030, its value is projected to reach $1.44 billion, reflecting a compound annual growth rate (CAGR) of 8.4%. This forecasted growth is driven by factors such as rising global drug production, a greater reliance on high-performance excipients, an increasing need for consistent formulation quality, the expansion of nutraceutical manufacturing, and ongoing improvements in excipient processing. Key trends shaping this period include a heightened demand for high-purity pharmaceutical excipients, more widespread application in tablet and capsule formulations, greater adoption in calcium supplement production, an increase in quality-controlled excipient manufacturing, and a stronger emphasis on materials that comply with regulatory standards.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharma Grade Calcium Sulphate Market Demand Drivers Creating New Revenue Opportunities

The expanding demand for pharmaceutical products is set to drive the pharma grade calcium sulphate market forward. Pharmaceuticals encompass drugs and medications created, manufactured, and applied to diagnose, treat, or prevent illnesses in humans and animals. This rising demand largely stems from the increasing prevalence of chronic diseases, which require more individuals to rely on long-term treatments for managing conditions like diabetes, cardiovascular ailments, and cancer. By acting as a high-purity excipient, pharma grade calcium sulphate improves drug formulations by ensuring consistent tablet hardness, stability, and controlled release of active ingredients. For example, in April 2024, Eurostat, an official statistical agency of the European Union based in Luxembourg, reported that EU imports of medicinal and pharmaceutical products grew by 6.1% in 2023, reaching $137.4 billion (€119 billion) compared to the prior year. Over the same timeframe, EU exports totaled $319.2 billion (€277 billion), creating a trade surplus of $182.0 billion (€158 billion). Consequently, the increasing demand for pharmaceuticals is fueling growth in the pharma grade calcium sulphate market.

Pharma Grade Calcium Sulphate Market Segment Breakdown: Which Categories Generate The Most Revenue?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

Pharma Grade Calcium Sulphate Market Trends Driving Strategic Industry Expansion

Key industry players in the pharma-grade calcium sulphate market are concentrating on developing novel products through the use of synthetic medical-grade bassanite, aimed at improving both the purity and consistency of calcium sulphate offerings. This synthetic medical-grade bassanite, a high-purity, partially dehydrated form of calcium sulphate (CaSO₄·0.5H₂O), facilitates the production of pharma-grade calcium sulphate by supplying a consistent, contaminant-free source that adheres to stringent regulatory criteria for medical and pharmaceutical applications. For example, in February 2025, Sree Chitra Tirunal Institute for Medical Sciences & Technology, a medical institute headquartered in India, introduced Caspro and Bonyx, two innovative drug-eluting bone graft products crafted from synthetic medical-grade bassanite to guarantee high purity, biocompatibility, and controlled drug delivery in advanced orthopedic settings. Caspro is a self-setting, moldable bone cement derived from calcium sulfate hemihydrate strengthened with phosphate ions, making it suitable for filling bone defects and enabling drug delivery directly at the implantation site for over 21 days. Bonyx comprises osteoconductive bioceramic beads that can be vacuum-loaded with antibiotics or other medications in liquid form, allowing for sustained drug release exceeding 30 days. These offerings mark a considerable advancement in localized therapy for bone infections and regeneration, showcasing how pharma-grade calcium sulfate can be applied in next-generation biomedical solutions that comply with rigorous global standards.

Pharma Grade Calcium Sulphate Market Key Players And Strategic Industry Positioning

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères

Access The Complete Pharma Grade Calcium Sulphate Market Report:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharma Grade Calcium Sulphate Market Geographic Analysis: Where Is Demand Growing The Fastest?

North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Pharma Grade Calcium Sulphate Market In 2026 And How Much Will It Reach By 2030?

The pharma grade calcium sulphate market has demonstrated significant expansion in recent years. Its valuation is set to increase from $0.96 billion in 2025 to $1.04 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. This past growth is largely attributable to factors such as the expansion in pharmaceutical manufacturing, a higher demand for solid dosage forms, the widening production of generic drugs, the increasing utilization of calcium-based excipients, and a stronger regulatory focus on excipient quality.

The pharma grade calcium sulphate market size is projected to experience substantial growth in the upcoming years. It is anticipated to achieve a value of $1.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This projected growth can be linked to factors such as the expansion of global drug production, the increasing adoption of high-performance excipients, a rising requirement for consistent formulation quality, the growth in nutraceutical manufacturing, and improvements in excipient processing. Significant trends for this forecast period include an elevated demand for high-purity pharmaceutical excipients, their increasing application in tablet and capsule formulations, greater utilization in calcium supplement production, the expansion of quality-controlled excipient manufacturing, and a concentrated effort on regulatory-compliant materials.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

What Influential Factors Are Boosting The Pharma Grade Calcium Sulphate Market Demand?

The market for pharma grade calcium sulphate is projected to expand significantly due to the increasing demand for pharmaceuticals. Pharmaceuticals encompass drugs and medical treatments created, produced, and utilized for disease diagnosis, treatment, or prevention in both human and animal populations. This escalating demand for pharmaceuticals stems largely from the increasing incidence of chronic illnesses, which necessitates long-term drug regimens for managing conditions like diabetes, cardiovascular diseases, and cancer in a greater number of people. Pharma grade calcium sulphate improves pharmaceutical formulations, functioning as a high-purity excipient essential for maintaining uniform tablet hardness, stability, and regulated release of active components. As an example, Eurostat, the European Union’s official statistical agency located in Luxembourg, reported in April 2024 that medicinal and pharmaceutical product imports into the EU rose by 6.1% in 2023, reaching a total of $137.4 billion (€119 billion) when compared to the prior year. Concurrently, EU exports for the same period amounted to $319.2 billion (€277 billion), leading to a trade surplus of $182.0 billion (€158 billion). Consequently, the expanding need for pharmaceuticals is a key factor propelling the growth of the pharma grade calcium sulphate market.

What Are The Core Segment Classifications In The Pharma Grade Calcium Sulphate Market?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

Which Trends Are Expected To Shape The Pharma Grade Calcium Sulphate Market?

Leading firms within the pharma grade calcium sulphate market are concentrating on creating novel products, leveraging synthetic medical-grade bassanite to improve the purity and uniformity of calcium sulphate offerings. Synthetic medical-grade bassanite, defined as a highly pure, partially dehydrated calcium sulphate (CaSO4·0.5H2O), facilitates the production of pharma-grade calcium sulphate by supplying a reliable, uncontaminated raw material that adheres to rigorous regulatory criteria for medical and pharmaceutical uses. An example of this is the launch in February 2025 by Sree Chitra Tirunal Institute for Medical Sciences & Technology, an India-based medical institute, of Caspro & Bonyx. These are groundbreaking drug-eluting bone graft products, created with synthetic medical-grade bassanite to guarantee superior purity, biocompatibility, and precise drug release for sophisticated orthopedic uses. Caspro is a self-curing, malleable bone cement derived from calcium sulfate hemihydrate, strengthened with phosphate ions, making it perfect for repairing bone deficiencies and releasing medications locally for more than 21 days. Bonyx, on the other hand, comprises osteoconductive bioceramic beads capable of being vacuum-loaded with antibiotics or other liquid medications, allowing for sustained drug delivery lasting over 30 days. These innovations mark a substantial advancement in targeted treatment for bone infections and regeneration, showcasing the potential of pharma-grade calcium sulphate in developing future biomedical solutions that comply with strict global benchmarks.

Who Are The Firms Contributing To The Pharma Grade Calcium Sulphate Market Ecosystem?

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères

Access The Complete Pharma Grade Calcium Sulphate Market Report:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

Which Area Represents The Largest Portion Of The Pharma Grade Calcium Sulphate Market?

North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pharma Grade Calcium Sulphate Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

Browse Through More Reports Similar to the Global Pharma Grade Calcium Sulphate Market 2026, By The Business Research Company

Potassium Sulphate Market Report 2026

https://www.thebusinessresearchcompany.com/report/potassium-sulphate-global-market-report

Calcium Aluminosilicate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-aluminosilicate-global-market-report

Calcium Nitrate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-nitrate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Pharma Grade Calcium Sulphate Market Grow Between 2026 And 2030?

The size of the pharma grade calcium sulphate market has experienced significant expansion over recent years. This market is projected to expand from $0.96 billion in 2025 to reach $1.04 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 8.5%. Factors contributing to this historical growth include the expansion of pharmaceutical manufacturing, a rise in the demand for solid dosage forms, the increase in generic drug production, the growing application of calcium-based excipients, and a stronger regulatory focus on the quality of excipients.

The pharma grade calcium sulphate market is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach $1.44 billion, exhibiting a compound annual growth rate (CAGR) of 8.4%. This projected growth during the forecast period stems from factors such as increased global drug manufacturing, the expanding application of high-performance excipients, a greater need for uniform formulation quality, the expansion of nutraceutical production, and ongoing improvements in excipient processing. Key trends foreseen for this period encompass a heightened demand for high-purity pharmaceutical excipients, their broader integration into tablet and capsule formulations, an uptick in their use for calcium supplement production, an increase in quality-controlled excipient manufacturing, and a stronger emphasis on materials that comply with regulations.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

What Primary Drivers Are Shaping The Pharma Grade Calcium Sulphate Market?

The increasing demand for pharmaceuticals is projected to drive the growth of the pharma grade calcium sulphate market in the coming period. Pharmaceuticals are substances, including drugs and medications, that are developed, manufactured, and administered to diagnose, treat, or prevent diseases in both humans and animals. The surge in pharmaceutical demand is primarily attributed to the rising prevalence of chronic conditions, necessitating long-term medications for individuals managing ailments such as diabetes, cardiovascular disorders, and cancer. Pharma grade calcium sulphate plays a crucial role in enhancing pharmaceutical formulations by acting as a high-purity excipient, which ensures consistent tablet hardness, overall stability, and the controlled release of active ingredients. For instance, according to Eurostat, a Luxembourg-based official statistical agency of the European Union, in April 2024, imports of medicinal and pharmaceutical products into the EU saw a 6.1% increase in 2023, amounting to $137.4 billion (€119 billion) when compared to the preceding year. During the same timeframe, EU exports reached $319.2 billion (€277 billion), leading to a trade surplus of $182.0 billion (€158 billion). Therefore, the escalating demand for pharmaceuticals is a significant impetus behind the expansion of the pharma grade calcium sulphate market.

What Segment Categories Shape The Pharma Grade Calcium Sulphate Market Segment Landscape?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

What Trends Are Affecting The Growth Of The Pharma Grade Calcium Sulphate Market?

Companies operating within the pharma grade calcium sulphate market are concentrating on developing innovative products by leveraging synthetic medical-grade bassanite to enhance the purity and consistency of their calcium sulphate offerings. Synthetic medical-grade bassanite, a high-purity, partially dehydrated form of calcium sulphate (CaSO4·0.5H2O), enables the production of pharma-grade calcium sulphate by supplying a consistent, contaminant-free source that adheres to strict regulatory standards for medical and pharmaceutical applications. For instance, in February 2025, Sree Chitra Tirunal Institute for Medical Sciences & Technology, an India-based medical institute, launched Caspro & Bonyx, which are innovative drug-eluting bone graft products. These were developed using synthetic medical-grade bassanite to ensure high purity, biocompatibility, and controlled drug delivery for advanced orthopedic applications. Caspro is a self-setting, mouldable bone cement made from calcium sulfate hemihydrate reinforced with phosphate ions, making it ideal for filling bone defects and delivering drugs at the implantation site for over 21 days. Bonyx consists of osteoconductive bioceramic beads that can be vacuum-loaded with antibiotics or other liquid medications, facilitating sustained drug release for more than 30 days. These products represent a significant advancement in localized therapy for bone infections and regeneration, illustrating how pharma-grade calcium sulfate can be utilized in next-generation biomedical solutions that meet stringent international standards.

Who Are The Companies Operating Across The Pharma Grade Calcium Sulphate Market Value Chain?

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères

Get The Full Pharma Grade Calcium Sulphate Market Report:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

Which Region Is The Largest In The Pharma Grade Calcium Sulphate Market?

North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharma Grade Calcium Sulphate Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

Browse Through More Reports Similar to the Global Pharma Grade Calcium Sulphate Market 2026, By The Business Research Company

Potassium Sulphate Market Report 2026

https://www.thebusinessresearchcompany.com/report/potassium-sulphate-global-market-report

Calcium Aluminosilicate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-aluminosilicate-global-market-report

Calcium Nitrate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-nitrate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Pharma Grade Calcium Sulphate Market During The Forecast Period 2026–2030?

The pharma grade calcium sulphate market has demonstrated robust growth in recent years. It is forecast to expand from $0.96 billion in 2025 to $1.04 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. The expansion witnessed in the historic period is attributable to growth in pharmaceutical manufacturing, increased demand for solid dosage forms, expansion of generic drug production, rising use of calcium-based excipients, and regulatory emphasis on excipient quality.

The market for pharma grade calcium sulphate is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $1.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. Factors contributing to this growth during the forecast period include an increase in worldwide drug manufacturing, the expanding application of high-performance excipients, a heightened need for uniform formulation quality, the enlargement of nutraceutical production, and progress in excipient processing techniques. Key developments expected during this period involve a surge in the need for high-purity pharmaceutical excipients, their increased utilization in tablet and capsule formulations, greater integration into calcium supplement production, the scaling up of quality-controlled excipient manufacturing, and an intensified emphasis on materials that comply with regulations.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

What Drivers Are Expected To Influence The Pharma Grade Calcium Sulphate Market During The Forecast Period?

The future expansion of the pharma grade calcium sulphate market is anticipated to be fueled by the increasing need for pharmaceuticals. Pharmaceuticals encompass drugs and medicines created, produced, and utilized for the diagnosis, treatment, or prevention of illnesses in both humans and animals. This escalating demand for pharmaceuticals largely stems from the increasing incidence of chronic diseases, as more people require ongoing medications to manage ailments like diabetes, cardiovascular disorders, and cancer. Pharma grade calcium sulphate plays a crucial role in improving pharmaceutical formulations, acting as a high-purity excipient that guarantees uniform tablet hardness, stability, and the regulated release of active components. For example, data from April 2024, provided by Eurostat, the official statistical agency of the European Union located in Luxembourg, indicated that imports of medicinal and pharmaceutical goods into the EU rose by 6.1% in 2023, reaching a total of $137.4 billion (€119 billion) compared to the prior year. In the identical timeframe, EU exports amounted to $319.2 billion (€277 billion), resulting in a trade surplus of $182.0 billion (€158 billion). Consequently, the rising requirement for pharmaceuticals is propelling the growth of the pharma grade calcium sulphate market.

What Market Segments Are Evaluated Within The Pharma Grade Calcium Sulphate Market?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

What Industry Trends Are Redefining The Pharma Grade Calcium Sulphate Market?

Leading companies in the pharma grade calcium sulphate market are concentrating on developing advanced products by incorporating synthetic medical-grade bassanite, aiming to boost the purity and consistency of calcium sulphate items. Synthetic medical-grade bassanite, a highly pure, partially dehydrated form of calcium sulphate (CaSO4·0.5H2O), aids in the production of pharma-grade calcium sulphate by offering a dependable, contaminant-free source that meets strict regulatory mandates for medical and pharmaceutical uses. For instance, in February 2025, Sree Chitra Tirunal Institute for Medical Sciences & Technology, an India-based medical institute, launched Caspro & Bonyx, which are innovative drug-eluting bone graft products created using synthetic medical-grade bassanite to ensure high purity, biocompatibility, and controlled drug delivery for sophisticated orthopedic applications. Caspro is a self-setting, mouldable bone cement made from calcium sulfate hemihydrate strengthened with phosphate ions, perfectly suited for filling bone defects and providing drug delivery at the implantation site for over 21 days. Bonyx consists of osteoconductive bioceramic beads that can be vacuum-loaded with antibiotics or other medications in liquid form, allowing for sustained drug release for more than 30 days. These products represent a significant advancement in localized therapy for bone infections and regeneration, illustrating how pharma-grade calcium sulfate can be utilized in next-generation biomedical solutions that adhere to stringent international standards.

Who Are The Top Market Participants Influencing The Pharma Grade Calcium Sulphate Market?

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères

Read the full pharma grade calcium sulphate market report here:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

Which Region Is Forecast To Lead The Pharma Grade Calcium Sulphate Market In Terms Of Market Size?

North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pharma Grade Calcium Sulphate Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24372&type=smp

Browse Through More Reports Similar to the Global Pharma Grade Calcium Sulphate Market 2026, By The Business Research Company

Potassium Sulphate Market Report 2026

https://www.thebusinessresearchcompany.com/report/potassium-sulphate-global-market-report

Calcium Aluminosilicate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-aluminosilicate-global-market-report

Calcium Nitrate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-nitrate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharma grade calcium sulphate market from 2026–2035 with trusted insights from The Business Research Company

How much is the Pharma Grade Calcium Sulphate Market valued at in 2026, and what valuation is forecast for 2030?

The pharma grade calcium sulphate market size has seen significant growth in recent years. This market is set to expand from $0.96 billion in 2025 to $1.04 billion in 2026, driven by a compound annual growth rate (CAGR) of 8.5%. The historical growth can be attributed to several factors, including the expansion in pharmaceutical manufacturing, increased demand for solid dosage forms, the growth of generic drug production, rising utilization of calcium-based excipients, and a strong regulatory focus on excipient quality.

The market for pharma grade calcium sulphate is projected to experience substantial expansion in the coming years, reaching $1.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This expansion throughout the forecast period stems from factors such as an increase in global drug production, the growing application of high-performance excipients, a heightened need for uniform formulation quality, the enlargement of nutraceutical manufacturing, and innovations in excipient processing. Significant trends anticipated during this period encompass a surging requirement for high-purity pharmaceutical excipients, their increasing integration into tablet and capsule formulations, greater uptake in the production of calcium supplements, the broadening of quality-controlled excipient manufacturing, and an intensified emphasis on materials that comply with regulations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

What Drivers Are Influencing The Growth Of The Pharma Grade Calcium Sulphate Market?

The increasing need for pharmaceuticals is anticipated to drive the expansion of the pharma grade calcium sulphate market in the future. Pharmaceuticals are defined as drugs and medicines created, produced, and utilized for the diagnosis, treatment, or prevention of illnesses in both humans and animals. This rising demand for pharmaceuticals primarily stems from the increasing occurrence of chronic illnesses, leading more people to need ongoing medications for managing conditions like diabetes, cardiovascular disorders, and cancer. Pharma grade calcium sulphate improves pharmaceutical formulations by acting as a high-purity excipient, which guarantees uniform tablet hardness, stability, and the regulated release of active components. For example, in April 2024, Eurostat, the official statistical agency of the European Union located in Luxembourg, reported that imports of medicinal and pharmaceutical products into the EU rose by 6.1% in 2023, reaching a total of $137.4 billion (€119 billion) when compared to the prior year. Concurrently, EU exports amounted to $319.2 billion (€277 billion), creating a trade surplus of $182.0 billion (€158 billion). Consequently, the increasing need for pharmaceuticals is fueling the expansion of the pharma grade calcium sulphate market.

What Segments Are Included Within The Pharma Grade Calcium Sulphate Market?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

Which Trends Are Guiding The Evolution Of The Pharma Grade Calcium Sulphate Market?

Leading companies within the pharma grade calcium sulphate market are concentrating their efforts on creating innovative products, specifically through the application of synthetic medical-grade bassanite, to elevate the purity and consistency of calcium sulphate offerings. Synthetic medical-grade bassanite, which is a high-purity and partially dehydrated form of calcium sulphate (CaSO₄·0.5H₂O), plays a crucial role in manufacturing pharma-grade calcium sulphate by supplying a consistent and contaminant-free material that adheres to stringent regulatory requirements for medical and pharmaceutical uses. For instance, in February 2025, the Sree Chitra Tirunal Institute for Medical Sciences & Technology, an India-based medical institute, launched Caspro & Bonyx. These innovative drug-eluting bone graft products were developed utilizing synthetic medical-grade bassanite to ensure high purity, biocompatibility, and controlled drug delivery for advanced orthopedic applications. Caspro is a self-setting, mouldable bone cement composed of calcium sulfate hemihydrate enhanced with phosphate ions, making it ideal for filling bone defects and delivering drugs at the implantation site for over 21 days. Bonyx consists of osteoconductive bioceramic beads that can be vacuum-loaded with antibiotics or other medications in liquid form, facilitating sustained drug release for more than 30 days. These advancements signify a considerable progression in localized therapy for bone infections and regeneration, illustrating the potential of pharma-grade calcium sulfate in developing next-generation biomedical solutions that comply with rigorous international standards.

Who Are The Major Companies Operating In The Pharma Grade Calcium Sulphate Market?

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Pharma Grade Calcium Sulphate Market?

North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharma Grade Calcium Sulphate Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24372&type=smp

Browse Through More Reports Similar to the Global Pharma Grade Calcium Sulphate Market 2026, By The Business Research Company

Potassium Sulphate Market Report 2026

https://www.thebusinessresearchcompany.com/report/potassium-sulphate-global-market-report

Calcium Aluminosilicate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-aluminosilicate-global-market-report

Calcium Nitrate Market Report 2026

https://www.thebusinessresearchcompany.com/report/calcium-nitrate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharma grade calcium sulphate market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Pharma Grade Calcium Sulphate Market Size?

The pharma grade calcium sulphate market has shown robust expansion in recent years. It is anticipated to increase from $0.89 billion in 2024 to $0.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.9%. This historical market growth can be attributed to the rising demand for pharmaceutical applications, its expanded use in various medical treatments and surgeries, greater public awareness regarding bone health, continuous advancements in drug delivery systems, and the increasing prevalence of diseases affecting bones.

The market size for pharma grade calcium sulphate is projected to experience robust expansion over the coming years. This market is anticipated to reach “$1.33 billion” by 2029, demonstrating a compound annual growth rate (CAGR) of “8.4%”. Factors contributing to this growth during the forecast period include a growing aging population, an increase in bone and joint disorders, higher healthcare spending in emerging economies, the expanding application of calcium sulfate in regenerative medicine, and the overall expansion of the pharmaceutical industry. Key trends anticipated within the forecast period encompass a shift towards organic and natural sources of calcium sulfate, technological advancements in calcium sulfate synthesis methods, an emphasis on sustainability and eco-friendly manufacturing practices, progress in controlled-release drug delivery technologies, and the development of advanced drug formulations.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

What Core Market Drivers Are Expanding The Pharma Grade Calcium Sulphate Industry?

The increasing need for pharmaceuticals is anticipated to fuel the expansion of the pharma grade calcium sulphate market in the future. Pharmaceuticals are defined as drugs and medicines created, produced, and utilized for diagnosing, treating, or preventing ailments in both humans and animals. This escalating demand for pharmaceuticals largely stems from the increasing incidence of chronic illnesses, leading more people to require ongoing medications for conditions like diabetes, heart disorders, and cancer. Pharma grade calcium sulphate improves pharmaceutical preparations by functioning as a high-purity inactive ingredient, guaranteeing uniform tablet firmness, stability, and precise release of active compounds. For example, data from June 2023, provided by the European Federation of Pharmaceutical Industries and Associations, a trade body based in Belgium, indicated that in 2022, North America held 52.3% of worldwide pharmaceutical sales, with Europe making up 22.4%. Consequently, the increasing demand for pharmaceuticals is propelling the growth of the pharma grade calcium sulphate market.

What Segment Insights Are Highlighted In The Pharma Grade Calcium Sulphate Market Report?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

Which Notable Trends Are Transforming The Pharma Grade Calcium Sulphate Market Outlook?

Leading firms within the pharma grade calcium sulphate market are concentrating on creating novel products, leveraging synthetic medical-grade bassanite to improve the purity and uniformity of their calcium sulphate offerings. This synthetic medical-grade bassanite, identified as a highly pure, partially dehydrated variant of calcium sulphate (CaSO4·0.5H2O), facilitates the production of pharma-grade calcium sulphate by offering a stable, impurity-free material that adheres to stringent regulatory requirements for medical and pharmaceutical uses. An example illustrating this trend is the launch in February 2025 by Sree Chitra Tirunal Institute for Medical Sciences & Technology, an Indian medical institution, of Caspro & Bonyx. These are advanced drug-eluting bone graft solutions, formulated with synthetic medical-grade bassanite to guarantee exceptional purity, biocompatibility, and controlled drug release for sophisticated orthopedic uses. Specifically, Caspro serves as a self-setting, adaptable bone cement, crafted from calcium sulfate hemihydrate fortified with phosphate ions, making it suitable for addressing bone defects and providing localized drug delivery at the implantation site for a duration exceeding 21 days. Bonyx, conversely, comprises osteoconductive bioceramic beads capable of being vacuum-loaded with antibiotics or various medications in liquid state, allowing for prolonged drug liberation over more than 30 days. Such products mark a notable advancement in localized treatment strategies for bone infections and regeneration, showcasing the potential of pharma-grade calcium sulfate in developing future biomedical solutions that comply with rigorous international benchmarks.

Which Firms Are Driving Innovation Within The Pharma Grade Calcium Sulphate Market?

Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Honeywell International Inc., Merck KGaA, Solvay S.A., Avantor Inc., MP Biomedicals LLC, Spectrum Chemical Manufacturing Corp., Anhui Sunhere Pharmaceutical Excipients, SRL Chemical, GFS Chemicals Inc., American Elements, Loba Chemie Pvt. Ltd., Annexe Chem, Noah Technologies Corporation, Junsei Chemical Co. Ltd, Nikunj Chemicals, Shiva Inorganics, Huzhou Zhanwang Pharmaceutical Co. Ltd., China Shuanghua Gypsum, Jingmen City Leixin Gypsum

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

What Regional Trends Are Shaping Growth In The Pharma Grade Calcium Sulphate Market?

North America was the largest region in the pharma grade calcium sulphate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24372&type=smp

Browse Through More Reports Similar to the Global Pharma Grade Calcium Sulphate Market 2025, By The Business Research Company

Calcium Carbide Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/calcium-carbide-global-market-report

Calcium Peroxide Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/calcium-peroxide-global-market-report

Calcium Channel Blocker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/calcium-channel-blocker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Pharma Grade Calcium Sulphate Market’s Growth Trajectory From 2025 To 2034?

In recent times, there has been a substantial surge in the market size of pharma grade calcium sulphate. The market, which stood at $0.89 billion in 2024, is projected to increase to $0.96 billion by 2025, growing at a compound annual growth rate (CAGR) of 7.9%. This expansion during the historical period is a result of the augmenting demand for pharmaceutical applications, enhanced use in medical treatments and surgical procedures, heightened public consciousness about the importance of bone health, progress in drug delivery systems, and the growing incidence of bone-related illnesses.

The pharmaceutical grade calcium sulfate market is anticipated to experience significant growth in the coming years, expanding to $1.33 billion in 2029 with a compound annual growth rate (CAGR) of 8.4%. This growth in the prediction period is primarily linked to the increase in the aging population, the upsurge in bone and joint disorders, a boost in healthcare expenditure in developing economies, the rising use of calcium sulfate in regenerative medicine, and the growth of the pharmaceutical industry. Major trends observed during this forecast period include a shift towards organic and natural calcium sulfate sources, technological progress in calcium sulfate synthesis methods, emphasis on sustainable and environmentally friendly manufacturing methods, advancements in controlled-release drug delivery systems, and sophisticated drug formulations.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

What Are the Core Market Drivers Propelling Growth in the Pharma Grade Calcium Sulphate Industry?

The pharmaceutical industry’s escalating needs are predicted to fuel the expansion of the pharma grade calcium sulphate market in the future. When referring to pharmaceuticals, we’re talking about drugs and medicines that are produced and employed for the diagnosis, treatment, or prevention of diseases in people and animals. The surge in demand for pharmaceuticals primarily stems from the increasing rates of chronic illnesses, leading to a heightened need for long-term medication for conditions such as diabetes, heart diseases, and cancer. Pharma grade calcium sulphate improves pharmaceutical products by acting as a pure excipient that guarantees consistent tablet hardness, stability, and controlled distribution of active components. The European Federation of Pharmaceutical Industries and Associations, a trade association based in Belgium, reported in June 2023, that North America contributed 52.3% to global pharmaceutical sales in 2022, with Europe contributing 22.4%. Hence, the escalating demand for pharmaceuticals is boosting the expansion of the pharma grade calcium sulphate market.

How Is the Pharma Grade Calcium Sulphate Market Segmented?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24372&type=smp

Which Regions Are Driving the Next Phase of the Pharma Grade Calcium Sulphate Market Growth?

North America was the largest region in the pharma grade calcium sulphate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in thePharma Grade Calcium Sulphate Market Over the Coming Years?

Key players in the pharma grade calcium sulphate market are dedicating efforts towards the creation of innovative items by utilizing synthetic medical-grade bassanite to improve the purity and regulation of calcium sulphate products. The use of synthetic medical-grade bassanite, a highly pure, partially dehydrated variant of calcium sulphate (CaSO4·0.5H2O), supports the production of pharma-grade calcium sulphate, providing a dependable, contamination-free source that observes rigorous regulatory guidelines for medical and pharmaceutical utilization. An example of this approach was seen in February 2025, when the Sree Chitra Tirunal Institute for Medical Sciences & Technology, a medical institute based in India, introduced Caspro & Bonyx. These are groundbreaking drug-eluting bone graft products formulated using synthetic medical-grade bassanite ensuring high levels of purity, biocompatibility, and managed drug delivery for advanced orthopedic applications. Caspro is a moldable bone cement that sets itself, created from calcium sulfate hemihydrate complemented with phosphate ions, thus making it perfect for filling bone defects and administering drugs at the implantation site for over 21 days. Bonyx is comprised of osteoconductive bioceramic beads that can be loaded with antibiotics or other liquid form medicines via a vacuum, ensuring a consistent drug release for a period exceeding 30 days. These offerings illustrate a major advancement in localized treatment for bone infections and regeneration, showcasing the potential of pharma-grade calcium sulfate in the development of future biomedical solutions aligning with strict international standards.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

How Is the Pharma Grade Calcium Sulphate Market Defined and What Are Its Core Parameters?

Pharma grade calcium sulphate is a purified form of calcium sulphate (CaSO4) specifically processed and tested to meet stringent pharmaceutical standards for use in medicines and healthcare applications. It is typically used as a diluent or excipient in tablets and capsules due to its high purity, controlled particle size, and non-toxic nature.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24372

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Fast Is The Pharma Grade Calcium Sulphate Market Expected to Grow Between 2025 And 2029?

In recent years, we’ve noted significant growth in the size of the pharma grade calcium sulphate market. This market, which was valued at $0.89 billion in 2024, is expected to expand to $0.97 billion in 2025, reflecting a compound annual growth rate or CAGR of 9.0%. Several factors can be linked to the growth observed during the historic period. Among these are increased demand for its use in pharmaceutical applications, expanded use in medical treatments and surgeries, growing knowledge about the importance of bone health, developments in drug delivery systems, and a higher incidence of diseases related to the bones.

The pharmaceutical grade calcium sulphate industry is set to experience significant growth over the upcoming years, anticipated to reach a worth of $1.36 billion in 2029, with a compound annual growth rate (CAGR) of 8.8%. This projected surge during the forecast period is linked to factors such as the increasing ageing population, emerging cases of bone and joint disorders, enhanced health expenditure in developing economies, the growing application of calcium sulphate in regenerative medicine, and the pharmaceutical sector’s expansion. The forecast period is also likely to witness a shift towards the organic and natural derivation of calcium sulfate, innovations in synthesizing calcium sulfate, focus on sustainable and environment-friendly production techniques, advances in controlled-drug, release technologies, and refined drug formulations.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Pharma Grade Calcium Sulphate Market?

The expanding need for pharmaceuticals is projected to spur the development of the pharma grade calcium sulphate market in the future. Pharmaceuticals constitute drugs and medications which are designed, produced and employed to detect, cure, or inhibit illnesses in humans and animals. The escalating demand for pharmaceuticals chiefly springs from the increasing incidence of chronic diseases as a higher number of people necessitate long-term drugs to control conditions such as diabetes, cardiovascular diseases, and cancer. Pharma grade calcium sulphate bolsters pharmaceutical blends by functioning as a high-purity excipient ensuring persistent tablet hardness, stability and managed release of active elements. For example, in June 2023, as per the European Federation of Pharmaceutical Industries and Associations, a Belgian trade association, in 2022, North America comprised 52.3% of total global pharmaceutical sales, while Europe justified 22.4%. Hence, the multiplying demand for pharmaceuticals is encouraging the surge of the pharma grade calcium sulphate market.

Which Key Market Segments Comprise the Pharma Grade Calcium Sulphate Market and Drive Its Revenue Growth?

The pharma grade calcium sulphate market covered in this report is segmented –

1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite

2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents

3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution

Subsegments:

1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade

2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate

3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24372&type=smp

Which Areas Are Leading Regions in the Pharma Grade Calcium Sulphate Market Expansion Across the Globe?

North America was the largest region in the pharma grade calcium sulphate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in the Pharma Grade Calcium Sulphate Market Over the Coming Years?

Leading players in the pharma grade calcium sulphate market are turning their focus towards the creation of novel products using synthetic medical-grade bassanite to increase the purity and consistency of calcium sulphate products. Synthetic medical-grade bassanite, a form of calcium sulphate that is partially dehydrated and of high purity (CaSO₄·0.5H₂O), contributes to the production of pharma-grade calcium sulphate by providing a standardized and pollutant-free source that complies with strict regulations for medical and pharmaceutical applications. For instance, in February 2025, Caspro & Bonyx – innovative bone graft products capable of controlled drug release for advanced orthopedic applications – were launched by Sree Chitra Tirunal Institute for Medical Sciences & Technology, an Indian medical institution, using synthetic medical-grade bassanite. Caspro – a mouldable bone cement from calcium sulfate hemihydrate with phosphate ion reinforcement – is perfect for bone defect fillings and drug delivery at implantation sites for over 21 days. Bonyx comprises bioceramic beads that are osteoconductive which can be infused with liquid form antibiotics or other drugs under vacuum, enabling prolonged drug release for over 30 days. These innovations highlight a significant progression in localized treatment for bone infection and regeneration, showing the potential applications of pharma-grade calcium sulphate in creating advanced medical solutions that adhere to rigorous international standards.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharma-grade-calcium-sulphate-global-market-report

How Is the Pharma Grade Calcium Sulphate Market Conceptually Defined?

Pharma grade calcium sulphate is a purified form of calcium sulphate (CaSO₄) specifically processed and tested to meet stringent pharmaceutical standards for use in medicines and healthcare applications. It is typically used as a diluent or excipient in tablets and capsules due to its high purity, controlled particle size, and non-toxic nature.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24372&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model